KLRC2 and cytomegalovirus infection: Analysis of additional samples from vaccine trial participants (n = 3) at time points after natural acquisition of CMV infection (confirmed by PCR/seroconversion to non-vaccine CMV antigens) remained negative for NKG2C+ NK cells over the study timeframe (data not shown).